Aaron Gilbreath

With drug resistance on the rise, the world faces a potential health catastrophe from infections we can no longer fight. One English scientist is probing toilet seats and pools of nasty stuff to find cures the way earlier scientists did: in nature.

When a well-publicized Chinese tech company raised billions of dollars to become the Netflix of China, it diversified quickly, expanded from streaming into manufacturing, and challenged Apple and Tesla. When it fell apart, it fell hard.

Mexico’s most widespread, violent drug cartel has $20 billion dollars in savings, owns half the Jalisco police and keeps expanding. Instead of growing heroin or marijuana, they manufacture methamphetamine, which has a higher profit margin and requires no open fields. They flew under the DEA’s radar by selling in Europe, Asia and Australia instead of the […]

One person searches for the flavor of the pediatric amoxicillin that, despite the pain of the ear infection it treated, endeared itself to so many of us. It’s what you might call a pharmaceutical travelogue, following a different sort of chem-trail.

After a friendly Sufi sect decided to build an enormous religious sanctuary east of San Francisco, locals resisted, and nimbyism and misinformation challenged the basic American tenant of freedom of religion.

Tragedy struck, but we’re thinking about our commute. What’s wrong with us? Are we not grieving enough? Or is a return to banalities a healthy sign? A meditation on loss and melancholy.

A man visits the Croatian town where Leo Sternbach, the inventor of benzodiazepines, was born. Benzos were the author’s drug of choice. Thankfully the town’s Margherita pizza outsells the Valium.